June 2026
Published Jun 17, 2026RCTsNew this week
The study evaluated the effects of a diabetes-specific nutritional formula (DSNF-Pro) on postprandial glycemic control in prediabetic participants, finding significant reductions in glucose and c-peptide levels compared to a standard formula.
Interventions
Diabetes-specific nutritional formula-pro (DSNF-Pro)
Outcomes
C-peptide incremental area under the curve (iAUC)Glucose iAUC (OGTT)Postprandial insulin AUC
Added to Dediabetes Jun 17, 2026
View studyPublished Jun 17, 2026RCTsNew this week
This study evaluated the effects of semaglutide combined with insulin therapy on glycemic control and renal function in elderly patients with type 2 diabetes, finding significant improvements in several metabolic parameters.
Interventions
Insulin therapy
Outcomes
24-Hour Urinary Protein (24hUpr)Adverse events incidenceEndothelin-1 (ET-1)+9 more
Added to Dediabetes Jun 17, 2026
View studyPublished Jun 15, 2026RCTsNew this week
This study compared the effectiveness of nutritional therapy and alpha-glucosidase inhibitors in managing type 2 diabetes, finding significant reductions in glucose levels with both interventions.
Interventions
AcarboseLow glycemic index treatment (LGIT)Voglibose
Outcomes
24-hour glucoseGlucose area under the curve (AUC)Mean amplitude of glycemic excursions (MAGE)+2 more
Added to Dediabetes Jun 15, 2026
View studyPublished Jun 15, 2026RCTsNew this week
This study examined the impact of continuous glucose monitoring on glycemic control in diabetes patients, finding significant reductions in HbA1c and fasting plasma glucose levels.
Interventions
Continuous glucose monitoring
Outcomes
BMIFasting blood sugar (FBS)HbA1c+1 more
Added to Dediabetes Jun 15, 2026
View studyPublished Jun 14, 2026RCTsNew this week
This study evaluated the effects of mulberry twig alkaloids combined with continuous subcutaneous insulin infusion on glycemic variability in type 2 diabetes patients, finding significant improvements in several glycemic metrics.
Interventions
Continuous subcutaneous insulin infusionInsulin pump plus Mulberry twig extract therapy
Outcomes
Blood glucoseCoefficient of variationGlucose variability+6 more
Added to Dediabetes Jun 14, 2026
View studyPublished Jun 14, 2026RCTsNew this week
Switching from premixed insulin to the insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) improved glycemic control in participants with type 2 diabetes.
Interventions
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)
Outcomes
Body weightDiabetes-related misconceptionsFasting blood sugar (FBS)+3 more
Added to Dediabetes Jun 14, 2026
View studyPublished Jun 14, 2026RCTsNew this week
This study evaluated the impact of tighter glycaemic control in women with gestational diabetes. It found a reduction in serious health outcomes for infants but an increase in serious maternal health outcomes.
Interventions
Less tight glycemic controlTighter glycemic control
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Serious maternal health outcomeSerious perinatal adverse events
Added to Dediabetes Jun 14, 2026
View studyPublished Jun 14, 2026RCTsNew this week
This study investigated the acute effects of raw cinnamon on post-meal glucose spikes in type 2 diabetes patients, finding that cinnamon in water reduced glucose spikes while capsules did not.
Interventions
Control (No cinnamon)Raw cinnamon capsulesRaw cinnamon powder
Outcomes
Glucose iAUC (OGTT)Postprandial blood glucose
Added to Dediabetes Jun 14, 2026
View studyPublished Jun 13, 2026RCTs
This study investigated the effects of interval walking on postprandial glycemic control in individuals with type 2 diabetes, finding significant improvements with one of the walking interventions.
Interventions
Control (No walking)Interval walking
Outcomes
Postprandial blood glucose
Added to Dediabetes Jun 13, 2026
View studyPublished Jun 13, 2026RCTs
This study evaluated the cost-effectiveness of various glucose-lowering agents in type 2 diabetes patients, finding significant reductions in HbA1c levels.
Interventions
DulaglutideEmpagliflozinLiraglutide+3 more
Outcomes
BMIEstimated glomerular filtration rateHDL cholesterol+4 more
Added to Dediabetes Jun 13, 2026
View study